Literature DB >> 3950401

Natural antibodies to interferon-alpha and interferon-beta are a common feature of inbred mouse strains.

J De Maeyer-Guignard, E De Maeyer.   

Abstract

Neutralizing antibodies to murine interferon-alpha (MuIFN-alpha) and MuIFN-beta of the immunoglobulin (Ig)G and IgM class were naturally present in sera of BALB/c and C57BL/6 mice of four different age groups, ranging from 1 to 15 mo. These antibodies not only neutralized IFN made by C-243 cells (Swiss genotype), but also isogenic IFN-alpha and IFN-beta, and can therefore be considered to be real autoantibodies. Natural anti-MuIFN antibodies were also found in the sera of mice from 12 other inbred strains, and seem to be a common feature of inbred mouse strains.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3950401

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Endogeneous interferon alpha/beta produced by murine Kupffer cells augments liver-associated natural killing activity.

Authors:  M Werner-Wasik; W von Muenchhausen; J P Nolan; S A Cohen
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Cytokines in health and disease.

Authors:  L Borecký
Journal:  World J Microbiol Biotechnol       Date:  1992-12       Impact factor: 3.312

Review 3.  Expression of the genes of interferons and other cytokines in normal and diseased tissues of man.

Authors:  M G Tovey
Journal:  Experientia       Date:  1989-06-15

4.  Mouse natural autoantibodies can interfere with murine alpha and beta interferons.

Authors:  P Matsiota; M F Saron; J C Guillon; S Avrameas
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

5.  Spontaneous interferon-alpha antibodies in a patient with pure red cell aplasia and recurrent cutaneous carcinomas.

Authors:  O Prümmer; N Frickhofen; W Digel; H Heimpel; F Porzsolt
Journal:  Ann Hematol       Date:  1991 Feb-Mar       Impact factor: 3.673

6.  High avidity IFN-neutralizing antibodies in pharmaceutically prepared human IgG.

Authors:  C Ross; M Svenson; M B Hansen; G L Vejlsgaard; K Bendtzen
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.